Heron Therapeutics
HRTX
#8256
Rank
โ‚ฌ0.20 B
Marketcap
1,13ย โ‚ฌ
Share price
0.00%
Change (1 day)
-26.62%
Change (1 year)

Heron Therapeutics (HRTX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.21 Billion

According to Heron Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Heron Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.22 B11.31%
2023-12-31โ‚ฌ0.20 B-13.96%
2022-12-31โ‚ฌ0.23 B-13.33%
2021-12-31โ‚ฌ0.26 B-6.09%
2020-12-31โ‚ฌ0.28 B-37.2%
2019-12-31โ‚ฌ0.45 B13.3%
2018-12-31โ‚ฌ0.40 B106.89%
2017-12-31โ‚ฌ0.19 B204.39%
2016-12-31โ‚ฌ64.15 M-49.11%
2015-12-31โ‚ฌ0.12 B99.95%
2014-12-31โ‚ฌ63.05 M14.66%
2013-12-31โ‚ฌ54.98 M29.95%
2012-12-31โ‚ฌ42.31 M182.6%
2011-12-31โ‚ฌ14.97 M584.17%
2010-12-31โ‚ฌ2.18 M-64.97%
2009-12-31โ‚ฌ6.24 M-25.98%
2008-12-31โ‚ฌ8.44 M-66.65%
2007-12-31โ‚ฌ25.3 M93.56%
2006-12-31โ‚ฌ13.07 M72.68%
2005-12-31โ‚ฌ7.57 M-39.63%
2004-12-31โ‚ฌ12.54 M20.04%
2003-12-31โ‚ฌ10.44 M-38.57%
2002-12-31โ‚ฌ17 M-36.09%
2001-12-31โ‚ฌ26.61 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Alkermes
ALKS
โ‚ฌ2.00 B 835.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
โ‚ฌ1.11 B 421.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ0.25 B 21.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ1.26 B 493.20%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
โ‚ฌ0.14 B-31.78%๐Ÿ‡บ๐Ÿ‡ธ USA